PEDIATRICS Vol. 108 No. 2 August 2001, pp. 255-263
Received May 10, 2000; accepted Dec 14, 2000.
, and
From the * Neuroradiology, and Health Outcomes and Policy
Section, Department of Radiology, Children's Hospital Medical Center,
Cincinnati, Ohio; Objective. To assess the clinical and
economic consequences of 3 diagnostic strategies Materials and Methods. A decision-analytic Markov model
and cost-effectiveness analysis was performed incorporating the risk
group prior probability, MRI and CT sensitivity and specificity, tumor
survival, progression rates, and cost per strategy. Outcomes were based
on quality-adjusted life year (QALY) gained and incremental cost per
QALY gained.
Results. For low-risk children with chronic nonmigraine
headaches of >6 months' duration as the sole symptom (prior
probability of brain tumor 0.01%), no neuroimaging with close clinical
follow-up was less costly and more effective than the 2 neuroimaging
strategies. For the intermediate-risk children with migraine headache
and normal neurologic examination (prior probability of brain tumor 0.4%), CT-MRI was the most effective strategy but cost >$1 million per QALY gained compared with no neuroimaging. For high-risk children with headache of <6 months' duration and other clinical predictors of
a brain tumor such as an abnormal neurologic examination (prior probability of brain tumor 4%), the most effective strategy was MRI,
with cost-effectiveness ratio of $113 800 per QALY gained compared
with no imaging.
Conclusion. Our analysis suggests that MRI maximizes QALY
gained at a reasonable cost-effectiveness ratio in children with
headache at high risk of having a brain tumor. Conversely, the strategy
of no imaging with close clinical follow-up is cost saving in low-risk children. Although the CT-MRI strategy maximizes QALY gained in the
intermediate-risk patients, its additional cost per QALY gained is
high. In children with headache, appropriate selection of patients and diagnostic strategy may maximize quality-adjusted life expectancy and decrease costs of medical workup.
Department of Health Policy and Management,
Harvard School of Public Health, Boston, Massachusetts; and § Division
of Neuro-Oncology, Department of Neurology, Children's Hospital
Medical School, Boston, Massachusetts.
magnetic resonance
imaging (MRI), computed tomography followed by MRI for positive results
(CT-MRI), and no neuroimaging with close clinical follow-up
in the
evaluation of children with headache suspected of having a brain tumor.
Three risk groups based on clinical variables were evaluated.
This article has been cited by other articles:
![]() |
B. C. Reulecke, C. G. Erker, B. J. Fiedler, T.-U. Niederstadt, and G. Kurlemann Brain Tumors in Children: Initial Symptoms and Their Influence on the Time Span Between Symptom Onset and Diagnosis J Child Neurol, February 1, 2008; 23(2): 178 - 183. [Abstract] [PDF] |
||||
![]() |
I. Griebsch, J. Coast, and J. Brown Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health Pediatrics, May 1, 2005; 115(5): e600 - e614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Lewis, S. Ashwal, G. Dahl, D. Dorbad, D. Hirtz, A. Prensky, and I. Jarjour Practice parameter: Evaluation of children and adolescents with recurrent headaches: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology, August 27, 2002; 59(4): 490 - 498. [Abstract] [Full Text] [PDF] |
||||